All Stories

  1. Post-transplant diabetes mellitus requiring insulin identifies high-risk outcomes after solid organ transplantation
  2. Implantable vascularized endocrine constructs for clinically scalable insulin delivery
  3. Psychosocial implications, acceptability and ethics of screening for paediatric type 1 diabetes: a systematic review and mixed methods evidence synthesis
  4. Advances in Beta-cell Replacement Therapy for Diabetes—Insights From the 20th International Pancreas and Islet Transplant Association (IPITA) World Congress, Pisa, 2025
  5. From survival to freedom: redefining success in type 1 diabetes
  6. Gene Expression at the Pluripotency Stage Predicts Pancreatic Endocrine Differentiation in iPSC Clones
  7. From raw data to actionable insights: preprocessing real-world data for machine learning in diabetes care
  8. Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapy
  9. Diabetes and Pancreatic Cystic Neoplasms—Dangerous Liaisons
  10. An oncogenic KRAS-driven secretome involving TNFα promotes niche preparation prior to pancreatic cancer onset
  11. Diabetes does not modify the renal-protective effect of intravenous amino acids infusion after cardiac surgery
  12. Simultaneous Pancreas–Kidney Transplantation versus Kidney Alone: Interpreting Neutral Survival and Persistent Metabolic Advantages
  13. Simultaneous Pancreas–Kidney Versus Kidney Transplant Alone: Real-World Outcomes in a Propensity-Matched Global Cohort
  14. Induction of immune education in type 1 diabetes through controlled allogeneic islet rejection at onset: a monocentric open-label pilot study
  15. Blockade of CD155 and CD276 by Monoclonal Antibodies Fosters Immune Tolerance and Promotes Stable Engraftment of iPSC-Derived Islets in Allogeneic Humanized Mice
  16. Continuous Glucose Monitoring and Long-Term Assessment of Islet Function in Autologous Islet Transplantation after Total Pancreatectomy for Neoplasm: Preliminary Insights from a Prospective Study
  17. Continuous intraperitoneal insulin infusion as a valuable approach in patients with unstable type 1 diabetes: two case reports and a mini review of the literature
  18. Diabetes mellitus and pregnancy in Wolfram syndrome type 1: a case report with review of clinical and pathophysiological aspects
  19. Erratum. Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell–Derived β-Cells Harboring a Partially Functional WFS1 Variant. Diabetes 2025;74:1273–1288
  20. Islet autotransplantation in focal intraductal papillary mucinous neoplasms: Evaluating feasibility, safety, and metabolic outcomes in pancreatic resection
  21. Long-term follow-up of pancreatic islet transplantation in a patient with Wolfram syndrome: a case report
  22. Comparative Analysis of Islet Auto-Transplantation Outcome Classification Systems: Evaluating Concordance, Feasibility, and a Data-Driven Approach
  23. Future Directions and Clinical Trial Considerations for Novel Islet β-Cell Replacement Therapies for Type 1 Diabetes
  24. Islet autotransplantation in intraductal papillary mucinous neoplasm: A “Pole Pole” (slowly, slowly) path toward careful expansion of indications
  25. A multi-omics integration approach relying on circulating factors does not discern subtypes of childhood type 1 diabetes
  26. Aldolase-regulated G3BP1/2+ condensates control insulin mRNA storage in beta cells
  27. Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell–Derived β-Cells Harboring a Partially Functional WFS1 Variant
  28. Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy
  29. The Last Mile in Beta-Cell Replacement Therapy for Type 1 Diabetes: Time to Grow Up
  30. R-spondins secreted by human pancreas-derived mesenchymal stromal cells support pancreatic organoid proliferation
  31. Spheroids Composed of Reaggregated Neonatal Porcine Islets and Human Endothelial Cells Accelerate Development of Normoglycemia in Diabetic Mice
  32. Author Correction: Metabolic reprogramming of naïve regulatory T cells by IL-7 and IL-15 promotes their persistence and performance upon adoptive transfer
  33. Bioengineering of a human iPSC-derived vascularized endocrine pancreas for type 1 diabetes
  34. Metabolic reprogramming of naïve regulatory T cells by IL-7 and IL-15 promotes their persistence and performance upon adoptive transfer
  35. EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescents
  36. Roles for the long non-coding RNA Pax6os1/PAX6-AS1 in pancreatic beta cell function
  37. Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance
  38. LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype
  39. Exploring definitions of graft pancreatitis following pancreas transplantation: A scoping review
  40. Risk factors for bladder injuries during cesarean sections: insights from a 15 year experience at a tertiary care center and a systematic review with meta-analysis
  41. Exploring human pancreatic organoid modelling through single-cell RNA sequencing analysis
  42. Visualization of caudothalamic groove at expert fetal neurosonography
  43. SID/SIEDP expert consensus on optimizing clinical strategies for early detection and management of wolfram syndrome
  44. A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome
  45. Pig Xenotransplantation in Beta Cell Replacement: Addressing Challenges and Harnessing Potential for Type 1 Diabetes Therapy
  46. ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care
  47. Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
  48. Enhancing human islet xenotransplant survival and function in diabetic immunocompetent mice through LRH-1/NR5A2 pharmacological activation
  49. Clinical Translation and Implementation of a Bioartificial Pancreas Therapy: A Qualitative Study Exploring the Perspectives of People With Type 1 Diabetes
  50. Liraglutide treatment reverses unconventional cellular defects in induced pluripotent stem cell-derived β cells harboring a partially functional WFS1 variant
  51. Ketone bodies rescue T cell impairments induced by low glucose availability
  52. Assisted reproductive technology and the risk of fetal congenital heart disease: insights from a tertiary-care referral center
  53. Implications of noncoding regulatory functions in the development of insulinomas
  54. Cautious Optimism Warranted for Stem Cell-Derived Islet Transplantation in Type 2 Diabetes
  55. Severe West Nile Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections in a Patient With Thymoma and Anti–Type I Interferon Antibodies
  56. A Case Report of Metastatic Gastric Cancer Treated with Pembrolizumab during Pregnancy
  57. ASO Author Reflections: Bridging the Gap in PDAC Research: The Intraportal Model as a Platform for Studying Preclinical Liver Metastasis
  58. Establishment of a Transplantation Model of PDAC-Derived Liver Metastases
  59. Assisted Reproductive Technology and the risk of Fetal Congenital Heart Disease: insights from a Tertiary Care Referral Centre.
  60. Post-transcriptional regulation of insulin mRNA storage by G3BP1/2+condensates in beta cells
  61. Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions
  62. Autologous Pancreatic Islet Cell Transplantation Following Pancreatectomy for Pancreas Diseases Other Than Chronic Pancreatitis: A 15-y Study of the Milan Protocol
  63. A multi-omics integration approach relying on circulating factors does not discern endotypes in childhood type 1 diabetes.
  64. LDHB contributes to the regulation of lactate levels and basal insulin secretion in human pancreatic β cells
  65. Proinflammatory cytokines suppress nonsense-mediated RNA decay to impair regulated transcript isoform processing in pancreatic β cells
  66. Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity
  67. Improved Specificity of Glutamate Decarboxylase 65 Autoantibody Measurement Using Luciferase-Based Immunoprecipitation System Assays
  68. A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities
  69. AWFS1variant disrupting acceptor splice site uncovers the impact of alternative splicing on β cell apoptosis in a patient with Wolfram syndrome
  70. Proinflammatory Cytokines Suppress Nonsense-Mediated RNA Decay to Impair Regulated Transcript Isoform Processing in Pancreatic β-Cells
  71. Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge
  72. HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives
  73. IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer
  74. Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
  75. The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time
  76. Legal and Regulatory Challenges for Emerging Regenerative Medicine Solutions for Diabetes
  77. LRH-1/NR5A2 Activation Rewires Immunometabolism Blunting Inflammatory Immune Cell Progression in Individuals with Type 1 Diabetes and Enhances Human Islet Function in Mice
  78. Interleukin‐7 improves the fitness of regulatory T cells for adoptive transfer
  79. Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth
  80. Prevalence of undiagnosed celiac disease in the adult general population of Italy in 1990: Baseline reference for testing current increasing incidence?
  81. Improved specificity of glutamate decarboxylase 65 autoantibody measurement using luciferase-based immunoprecipitation system (LIPS) assays
  82. Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders
  83. Paediatric Wolfram syndrome Type 1: should gonadal dysfunction be part of the diagnostic criteria?
  84. Enhancing Beta Cell Replacement Therapies: Exploring Calcineurin Inhibitor-Sparing Immunosuppressive Regimens
  85. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry
  86. Reparixin improves survival in critically ill and transplant patients: A meta‐analysis
  87. The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age
  88. Comment on Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-Risk Pancreatojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Trial
  89. Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes
  90. Response to: Comment on: Pancreatectomy With Islet-Autotransplantation as Alternative for Pancreato-Duodenectomy in Patients With a High-Risk for Postoperative Pancreatic Fistula: The Jury Is Still Out
  91. Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset
  92. Pluripotent Stem Cell Therapy for Diabetes
  93. A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins
  94. Fat-to-Blood Recirculation of Partially Dysfunctional Pd-1+Cd4 Tconv Cells is Associated with Dysglycemia in Human Obesity
  95. High-Resolution Glucose Fate-Mapping Reveals LDHB-Dependent Lactate Production by Human Pancreatic Islets
  96. Implications of Noncoding Regulatory Functions in the Development of Insulinomas
  97. Bioengineered Vascularized Insulin Producing Endocrine Tissues
  98. Immune Evasive Stem Cell Islets
  99. High-resolution glucose tracing and in situ imaging reveals regulated lactate production in human pancreatic β cells
  100. Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2
  101. Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes
  102. Interventional Radiological Management and Prevention of Complications after Pancreatic Surgery: Drainage, Embolization and Islet Auto-Transplantation
  103. Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-risk Pancreatojejunostomy After Pancreaticoduodenectomy
  104. The immunological profile of SARS-CoV-2 infection in children is linked to clinical severity and age
  105. Genetic regulation of RNA splicing in human pancreatic islets
  106. A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma
  107. Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I−/− iPSCs for β cell replacement
  108. Cell Therapy for Type 1 Diabetes: From Islet Transplantation to Stem Cells
  109. Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report
  110. Treating iPSC-Derived β Cells with an Anti-CD30 Antibody–Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation
  111. Bioengineering the Vascularized Endocrine Pancreas: A Fine-Tuned Interplay Between Vascularization, Extracellular-Matrix-Based Scaffold Architecture, and Insulin-Producing Cells
  112. A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation
  113. A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-center cohort
  114. The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials
  115. Organoids: a systematic review of ethical issues
  116. In vivo and in vitro characterization of GL0034, a novel long‐acting glucagon‐like peptide‐1 receptor agonist
  117. Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency
  118. A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
  119. Ladarixin, an inhibitor of IL ‐8 receptors CXCR1 and CXCR2 , in new‐onset type 1 diabetes: a multicenter, randomized, double‐blind, placebo‐control...
  120. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
  121. Development and evaluation of low-volume tests to detect and characterise antibodies to SARS-CoV-2
  122. Glucose-Dependent miR-125b Is a Negative Regulator of β-Cell Function
  123. Bio-Engineering of Pre-Vascularized Islet Organoids for the Treatment of Type 1 Diabetes
  124. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
  125. Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization
  126. Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer
  127. Transgenic pigs expressing near infrared fluorescent protein—A novel tool for noninvasive imaging of islet xenotransplants
  128. COVID-19 in Solid Organ Transplant Recipient: Exploring Cumulative Incidence, Seroprevalence and Risk Factors for Disease Severity
  129. Case Report: Off-Label Liraglutide Use in Children With Wolfram Syndrome Type 1: Extensive Characterization of Four Patients
  130. Genetic regulation of RNA splicing in human pancreatic islets
  131. No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection
  132. Tfh and Tfr Cell Frequency in T1D and Control Subjects
  133. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19
  134. The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options
  135. Mini‐organs forum: how to advance organoid technology to organ transplant community
  136. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
  137. Correction to: Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy
  138. Seasonal betacoronavirus antibodies expansion post BNT161b2 vaccination associates with reduced SARS-CoV-2 VoCs neutralization
  139. Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia
  140. Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy
  141. Author Correction: PDX1LOW MAFALOW β-cells contribute to islet function and insulin release
  142. The MicroRNA Landscape of Acute Beta Cell Destruction in Type 1 Diabetic Recipients of Intraportal Islet Grafts
  143. Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2
  144. Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency
  145. US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?
  146. Dysglycemia after COVID-19 pneumonia: a six-month cohort study
  147. Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report
  148. Felix dies natalis, insulin… ceterum autem censeo “beta is better”
  149. Glucose-dependent miR-125b is a negative regulator of β-cell function
  150. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
  151. The microRNA Landscape of Acute Beta Cell Destruction in Type 1 Diabetic Recipients of Intraportal Islet Grafts
  152. Dysglyceamia after COVID-19 pneumonia: a six-month cohort study.
  153. Preexisting diabetes and COVID-associated hyperglycaemia in patients with COVID-19 pneumonia
  154. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19
  155. Neonatal diabetes mutations disrupt a chromatin pioneering function that activates the human insulin gene
  156. Transcriptional dynamics of induced pluripotent stem cell differentiation into β cells reveals full endodermal commitment and homology with human islets
  157. Total pancreatectomy as alternative to pancreatico-jejunal anastomosis in patients with high fistula risk score: the choice of the fearful or of the wise?
  158. The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells
  159. Circulating CXCL10 and IL-6 in solid organ donors after brain death predict graft outcomes
  160. Adipocyte-derived extracellular vesicles regulate survival and function of pancreatic β cells
  161. Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mouse
  162. COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival
  163. A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis
  164. Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies?
  165. A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children
  166. PDX1LOW MAFALOW β-cells contribute to islet function and insulin release
  167. Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia
  168. Generation of β Cells from iPSC of a MODY8 Patient with a Novel Mutation in the Carboxyl Ester Lipase (CEL) Gene
  169. Intrinsic factor autoantibodies by luminescent immuno-precipitation system in patients with corpus atrophic gastritis
  170. Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma
  171. SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans
  172. Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report
  173. COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain
  174. COVID-19 and islet transplantation: Different twins
  175. Rapamycin Plus Vildagliptin to Recover β-Cell Function in Long-Standing Type 1 Diabetes: A Double-Blind, Randomized Trial
  176. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
  177. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study
  178. Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis
  179. Autoantibodies against type I IFNs in patients with life-threatening COVID-19
  180. The actin modulator hMENA regulates GAS 6‐ AXL axis and pro‐tumor cancer/stromal cell cooperation
  181. Supporting physicians in the management of metabolic alterations in adult kidney transplant recipients: a comment on the joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the I...
  182. Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID)
  183. Roles for the long non-coding RNAPax6os1/PAX6-AS1in pancreatic beta cell identity and function
  184. 249-OR: A Randomized, Double-Blind Phase 2 Trial of the CXCR1/2 Inhibitor Ladarixin in Adult Patients with New-Onset Type 1 Diabetes
  185. Neonatal diabetes mutations disrupt a chromatin pioneering function that activates the human insulin gene
  186. Extracellular Vesicles Derived Human-miRNAs Modulate the Immune System in Type 1 Diabetes
  187. Standardized GMP-compliant scalable production of human pancreas organoids
  188. Re: Undiagnosed Prediabetes is Highly Prevalent in Primary Infertile Men—Results from a Cross-Sectional Study
  189. Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes
  190. Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children
  191. B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
  192. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” [Pancreatology 18(8) (2018) 847–854]
  193. Gender and Age Effects on the Rates of Infection and Deaths in Individuals with Confirmed SARS-CoV-2 Infection in Six European Countries
  194. Heterogeneity of Human Pancreatic Islet Isolation Around Europe: Results of a Survey Study
  195. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas
  196. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas
  197. Islet autotransplantation: Indication beyond chronic pancreatitis
  198. Treating diabetes with islet transplantation: Lessons from the Milan experience
  199. The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes
  200. Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses
  201. Selective local irradiation improves islet engraftment and survival in intra–bone marrow islet transplantation
  202. Islets for Research: Nothing Is Perfect, but We Can Do Better
  203. CCL 2/ MCP ‐1 and CXCL 12/ SDF ‐1 blockade by L‐aptamers improve pancreatic islet engraftment and survival in mouse
  204. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes
  205. Low-Carb and Ketogenic Diets in Type 1 and Type 2 Diabetes
  206. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer
  207. Biofabrication of a vascularized islet organ for type 1 diabetes
  208. Islet Allotransplantation in the Bone Marrow of Patients With Type 1 Diabetes
  209. Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice
  210. The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides new insights into the genetics of type 1 diabetes
  211. Diabetes‐free survival after extended distal pancreatectomy and islet auto transplantation for benign or borderline/malignant lesions of the pancreas
  212. Measurement of Autoantibodies to Gastric H+,K+-ATPase (ATP4A/B) Using a Luciferase Immunoprecipitation System (LIPS)
  213. Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome
  214. Pluripotent stem cell replacement approaches to treat type 1 diabetes
  215. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis
  216. Undiagnosed prediabetes is highly prevalent in primary infertile men - results from a cross-sectional study
  217. Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28–29 2017, Doha, Qatar)
  218. Differentiation of Sendai virus-reprogrammed iPSC into β cells, compared with human pancreatic islets and immortalized β cell line
  219. Study of 2009 H1N1 Pandemic Influenza Virus as a Possible Causative Agent of Diabetes
  220. Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes
  221. Regenerative Medicine and Diabetes: Targeting the Extracellular Matrix Beyond the Stem Cell Approach and Encapsulation Technology
  222. Human pancreatic islet 3D chromatin architecture provides insights into the genetics of type 2 diabetes
  223. The effects of kisspeptin on β-cell function, serum metabolites and appetite in humans
  224. Report of the Key Opinion Leaders Meeting on Stem Cell-derived Beta Cells
  225. Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound
  226. No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay
  227. Targeting GLP-1 receptor trafficking to improve agonist efficacy
  228. The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes
  229. Insulin-mimetic effects of short-term rapamycin in type 1 diabetic patients prior to islet transplantation
  230. The role of neutrophil-to-lymphocyte ratio in men with erectile dysfunction-preliminary findings of a real-life cross-sectional study
  231. Allo- and auto-percutaneous intra-portal pancreatic islet transplantation (PIPIT) for diabetes cure and prevention: the role of imaging and interventional radiology
  232. Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop
  233. Defining outcomes for beta cell replacement therapy: a work in progress
  234. Detection and Characterization of CD8+Autoreactive Memory Stem T Cells in Patients With Type 1 Diabetes
  235. The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes
  236. Proceedings of the signature series event of the international society for cellular therapy: “Advancements in cellular therapies and regenerative medicine in digestive diseases,” London, United Kingdom, May 3, 2017
  237. Anti-Inflammatory Strategies in Intrahepatic Islet Transplantation
  238. A novel LIPS assay for insulin autoantibodies
  239. Minimally Invasive Pancreatectomy plus Islet Autotransplantation for Benign Tumors of the Pancreatic Neck and Body
  240. Islet Cell or Pancreas Transplantation
  241. Islet Cell or Pancreas Transplantation
  242. Minimally Invasive Surgery of the Pancreas
  243. A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic β-Cells
  244. MiR‐184 expression is regulated by AMPK in pancreatic islets
  245. Bioengineering the Pancreas: Cell-on-Scaffold Technology
  246. Glucocorticoids Reprogram β-Cell Signaling to Preserve Insulin Secretion
  247. Integrating T cell metabolism in cancer immunotherapy
  248. miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA
  249. A preoperative score to predict early death after pancreatic cancer resection
  250. Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific
  251. Immunological Issues After Stem Cell-Based β Cell Replacement
  252. Modeling the Iatrogenic Pancreatic Cancer Risk After Islet Autotransplantation in Mouse
  253. Pancreatic Islet Transplantation Technologies: State of the Art of Micro- and Macro-Encapsulation
  254. Corrigendum: Advances in pancreatic islet monolayer culture on glass surfaces enable super-resolution microscopy and insights into beta cell ciliogenesis and proliferation
  255. Insulin-mimetic effects of short-term Rapamycin in type 1 diabetic patients prior islet transplantation
  256. Role of Extracellular vesicles in the crosstalk between adipocytes and pancreatic beta-cells
  257. Transplant Site Influences the Immune Response After Islet Transplantation
  258. Advances in pancreatic islet monolayer culture on glass surfaces enable super-resolution microscopy and insights into beta cell ciliogenesis and proliferation
  259. MP81-15 THE ROLE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN MEN WITH ERECTILE DYSFUNCTION – PRELIMINARY FINDINGS OF A REAL-LIFE CROSS-SECTIONAL STUDY
  260. MP81-20 THE ROLE OF SYSTEMIC INFLAMMATION IN DETERMINING HEALTH STATUS IN MEN WITH SEXUAL DYSFUNCTION – A WORRISOME SCENARIO IN YOUNG MEN
  261. PD13-07 MEN WITH INSULIN RESISTANCE ARE AT INCREASED RISK OF AZOOSPERMIA: RESULTS FROM A CROSS-SECTIONAL STUDY
  262. Salvage Islet Auto Transplantation After Relaparatomy
  263. Stem cells to restore insulin production and cure diabetes
  264. Human Pancreatic β Cell lncRNAs Control Cell-Specific Regulatory Networks
  265. Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients
  266. Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota
  267. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
  268. Establishment, characterization and long-term culture of human endocrine pancreas-derived microvascular endothelial cells
  269. MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells
  270. Human pancreatic β cell lncRNAs control cell-specific regulatory networks
  271. Abstract A07: Identification of endocrine/metabolic biomarkers associated to early PDC in a transgenic mouse model
  272. Ultra-marathon 100 km in an islet-transplanted runner
  273. Primary Human and Rat β-Cells Release the Intracellular Autoantigens GAD65, IA-2, and Proinsulin in Exosomes Together With Cytokine-Induced Enhancers of Immunity
  274. Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study
  275. Coxsackie–adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes
  276. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody
  277. Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose
  278. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients
  279. Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma
  280. Single-centre experience of extending indications for percutaneous intraportal islet autotransplantation (PIPIAT) after pancreatic surgery to prevent diabetes: feasibility, radiological aspects, complications and clinical outcome
  281. V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting Cells
  282. The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas
  283. Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 Diabetes
  284. Autologous Islet Transplantation in Patients Requiring Pancreatectomy: A Broader Spectrum of Indications Beyond Chronic Pancreatitis
  285. Islet Volume and Indexes of β-Cell Function in Humans
  286. The state of the art of islet transplantation and cell therapy in type 1 diabetes
  287. Sorcin Links Pancreatic β-Cell Lipotoxicity to ER Ca2+Stores
  288. Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma
  289. Enterovirus strain and type-specific differences in growth kinetics and virus-induced cell destruction in human pancreatic duct epithelial HPDE cells
  290. Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells
  291. MR Imaging Monitoring of Iron-Labeled Pancreatic Islets in a Small Series of Patients: Islet Fate in Successful, Unsuccessful, and Autotransplantation
  292. (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
  293. The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions
  294. Hepatic steatosis after islet transplantation: Can ultrasound predict the clinical outcome? A longitudinal study in 108 patients
  295. Islet autotransplantation as a safe procedure in patients with malignancy
  296. Monitoring Inflammation, Humoral and Cell-mediated Immunity in Pancreas and Islet Transplants
  297. Creation and implantation of acellular rat renal ECM-based scaffolds
  298. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment
  299. Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo
  300. Dual-Modal Magnetic Resonance/Fluorescent Zinc Probes for Pancreatic β-Cell Mass Imaging
  301. Diabetes After Pancreatic Surgery: Novel Issues
  302. Human islet distribution programme for basic research: activity over the last 5 years
  303. Calcineurin Inhibitor-Free Immunosuppressive Regimen in Type 1 Diabetes Patients Receiving Islet Transplantation
  304. β-Cell Differentiation of Human Pancreatic Duct–Derived Cells AfterIn VitroExpansion
  305. CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice
  306. Isolation, Characterization and Potential Role in Beta Cell-Endothelium Cross-Talk of Extracellular Vesicles Released from Human Pancreatic Islets
  307. Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients
  308. Autologous Islet Transplantation in Patients Requiring Pancreatectomy for Neoplasm
  309. The role of insulin in tumor recurrence after resection for pancreatic malignancy. Results of a prospective study
  310. Engraftment Versus Immunosuppression
  311. ADCY5 Couples Glucose to Insulin Secretion in Human Islets
  312. RFamide Peptides 43RFa and 26RFa Both Promote Survival of Pancreatic  -Cells and Human Pancreatic Islets but Exert Opposite Effects on Insulin Secretion
  313. The allocation of pancreas allografts on donor age and duration of intensive care unit stay: the experience of the North Italy Transplant program
  314. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants
  315. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection
  316. Relaparotomy for a pancreatic fistula after a pancreaticoduodenectomy: a comparison of different surgical strategies
  317. Combined laparoscopic spleen-preserving distal pancreatectomy and islet autotransplantation for benign pancreatic neoplasm
  318. Effects of exercise in a islet-transplanted half-marathon runner: outcome on diabetes management, training and metabolic profile
  319. Autologous Pancreatic Islet Transplantation in Human Bone Marrow. Diabetes 2013;62:3523-3531
  320. Liver Perfusion Changes Occurring During Pancreatic Islet Engraftment: A Dynamic Contrast-Enhanced Magnetic Resonance Study
  321. Human Pancreatic Islet Preparations Release HMGB1: (Ir)Relevance for Graft Engraftment
  322. β-cell transplantation in diabetes mellitus
  323. Rapamycin unbalances the polarization of human macrophages to M1
  324. Islet Transplantation Stabilizes Hemostatic Abnormalities and Cerebral Metabolism in Individuals With Type 1 Diabetes
  325. Lipotoxicity disrupts incretin-regulated human β cell connectivity
  326. Anti-Inflammatory Strategies to Enhance Islet Engraftment and Survival
  327. Extending Indications for Islet Autotransplantation in Pancreatic Surgery
  328. Autologous Pancreatic Islet Transplantation in Human Bone Marrow
  329. A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma (mPA)
  330. Mass spectrometric analysis reveals O-methylation of pyruvate kinase from pancreatic cancer cells
  331. Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets
  332. Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction
  333. Murine animal models for preclinical islet transplantation
  334. Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes
  335. Homeostatic T Cell Proliferation after Islet Transplantation
  336. Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
  337. Autologous islet transplantation to improve glycaemic control following extended pancreatectomy: indications and outcome
  338. Immunomodulation of CXCR2 Improves the Islet Engraftment and Survival after Liver Infusion
  339. Identification of Risk Factors Associated with the Induction/Increase of Donor Specific HLA Antibodies And/Or Islet Specific Autoantibodies after Islet Transplantation
  340. Laparoscopic Distal Pancreatectomy with Preservation of the Spleen and of the Splenic Vessels, with Autologous Islet Transplantation. a New Minimally Invasive Technique to Treat Benign Neoplasm of the Pancreatic Body. Case Series of 3 Patients
  341. Pilot Study to Assess Feasibility and Safety of Bone Marrow as Alternative Site in Islet Transplant Patients: 1 Year Follow-Up
  342. Relationship between full islet transplanted function and secondary diabetic complications: a case report
  343. Influenza A Viruses Grow in Human Pancreatic Cells and Cause Pancreatitis and Diabetes in an Animal Model
  344. Association of exercise-induced hyperinsulinaemic hypoglycaemia with MCT1-expressing insulinoma
  345. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation
  346. Human β Cell Transcriptome Analysis Uncovers lncRNAs That Are Tissue-Specific, Dynamically Regulated, and Abnormally Expressed in Type 2 Diabetes
  347. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction
  348. MS analysis reveals O-methylation of L-lactate dehydrogenase from pancreatic ductal adenocarcinoma cells
  349. No evidence of enteroviruses in the intestine of patients with type 1 diabetes
  350. Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes
  351. Gene Signatures Associated with Mouse Postnatal Hindbrain Neural Stem Cells and Medulloblastoma Cancer Stem Cells Identify Novel Molecular Mediators and Predict Human Medulloblastoma Molecular Classification
  352. Des-Acyl Ghrelin Fragments and Analogues Promote Survival of Pancreatic β-Cells and Human Pancreatic Islets and Prevent Diabetes in Streptozotocin-Treated Rats
  353. Proteomic Analysis Reveals Warburg Effect and Anomalous Metabolism of Glutamine in Pancreatic Cancer Cells
  354. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up
  355. Comparative Evaluation of Simple Indices of Graft Function After Islet Transplantation
  356. Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes
  357. Alternative Transplantation Sites for Pancreatic Islet Grafts
  358. Therapeutic plasticity of stem cells and allograft tolerance
  359. Fatty liver index and mortality: The cremona study in the 15th year of follow-up
  360. Proteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Metabolic Alterations
  361. Ask The Experts: Challenges and prospects for stem cell-based therapy in Type 1 diabetes
  362. Phosphoproteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Differential Phosphorylation of Cell Adhesion, Cell Junction and Structural Proteins
  363. Risks and Benefits of Transplantation in the Cure of Type 1 Diabetes: Whole Pancreas Versus Islet Transplantation. A Single Center Study
  364. Bone Marrow and Pancreatic Islets: An Old Story With New Perspectives
  365. Beta cell function during rapamycin monotherapy in long-term type 1 diabetes
  366. Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals: The Cremona Study
  367. Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: Implications for pathogenesis
  368. Role of CCL2/MCP-1 in Islet Transplantation
  369. ISLET CELL TRANSPLANTS FAIL DUE TO DONOR SPECIFIC ANTIBODIES
  370. Mass Spectrometry Analysis of the Post-Translational Modifications of α-Enolase from Pancreatic Ductal Adenocarcinoma Cells
  371. Co-Graft of Allogeneic Immune Regulatory Neural Stem Cells (NPC) and Pancreatic Islets Mediates Tolerance, while Inducing NPC-Derived Tumors in Mice
  372. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
  373. Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function
  374. A Photoprotein in Mouse Embryonic Stem Cells Measures Ca2+ Mobilization in Cells and in Animals
  375. Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
  376. Modulation of Early Inflammatory Reactions to Promote Engraftment and Function of Transplanted Pancreatic Islets in Autoimmune Diabetes
  377. Mesenchymal Stem Cells as Feeder Cells for Pancreatic Islet Transplants
  378. The Pancreatic Lymph-nodes of Type 1 Diabetic Patients Contain Epigenetically-imprinted Natural Regulatory T Cells which Lack Suppressive Function
  379. Improving the Procedure for Detection of Intrahepatic Transplanted Islets by Magnetic Resonance Imaging
  380. Bone marrow as an alternative site for islet transplantation
  381. Association Between Plasma Monocyte Chemoattractant Protein-1 Concentration and Cardiovascular Disease Mortality in Middle-Aged Diabetic and Nondiabetic Individuals
  382. Rapamycin does not adversely affect intrahepatic islet engraftment in mice and improves early islet engraftment in humans
  383. The contribution of hematopoietic stem cells to beta-cell replacement
  384. Mesenchymal Cells Appearing in Pancreatic Tissue Culture are Bone Marrow-Derived Stem Cells With the Capacity to Improve Transplanted Islet Function
  385. Ghrelin-producing epsilon cells in the developing and adult human pancreas
  386. Intrahepatic Islet Transplant in the Mouse: Functional and Morphological Characterization
  387. The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma
  388. β-cell transplantation for diabetes therapy
  389. Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells
  390. High Levels of Donor CCL2/MCP-1 Predict Graft-Related Complications and Poor Graft Survival After Kidney-Pancreas Transplantation
  391. Diabetes mellitus: an opportunity for therapy with stem cells?
  392. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells
  393. Transplant Estimated Function: A simple index to evaluate  -cell secretion after islet transplantation
  394. A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
  395. Relevance of Hyperglycemia on the Timing of Functional Loss of Allogeneic Islet Transplants: Implication for Mouse Model
  396. Culture Medium Modulates Proinflammatory Conditions of Human Pancreatic Islets Before Transplantation
  397. Increased intestinal permeability precedes clinical onset of type 1 diabetes
  398. Differential Effects of Immunosuppressive Drugs on Chemokine Receptor CCR7 in Human Monocyte-Derived Dendritic Cells: Selective Upregulation by Rapamycin
  399. Rapamycin Induces a Caspase-Independent Cell Death in Human Monocytes
  400. Stem Cells and the Kidney: A New Therapeutic Tool?
  401. Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
  402. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets
  403. Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4
  404. Donor and Isolation Variables Associated with Human Islet Monocyte Chemoattractant Protein-1 Release
  405. Tissue Factor and CCL2/Monocyte Chemoattractant Protein-1 Released by Human Islets Affect Islet Engraftment in Type 1 Diabetic Recipients
  406. A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile
  407. Tumor-Derived MUC1 Mucins Interact with Differentiating Monocytes and Induce IL-10highIL-12low Regulatory Dendritic Cell
  408. In vitro modulation of monocyte chemoattractant protein-1 release in human pancreatic islets
  409. From Pattern Recognition Receptor to Regulator of Homeostasis: The Double-Faced Macrophage Mannose Receptor
  410. Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program
  411. Fasting Plasma Leptin, Tumor Necrosis Factor-  Receptor 2, and Monocyte Chemoattracting Protein 1 Concentration in a Population of Glucose-Tolerant and Glucose-Intolerant Women: Impact on cardiovascular mortality
  412. Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells
  413. Rapamycin impairs antigen uptake of human dendritic cells1
  414. Strategies for tumor immune escape
  415. Human Pancreatic Islets Produce and Secrete MCP-1/CCL2: Relevance in Human Islet Transplantation
  416. Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability
  417. Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells
  418. EFFECTS OF CRYOPRESERVATION ON IN VITRO AND IN VIVO LONG-TERM FUNCTION OF HUMAN ISLETS1
  419. CRYOPRESERVATION OF HUMAN ISLETS OF LANGERHANS
  420. Glucocorticoids increase the endocytic activity of human dendritic cells
  421. Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells
  422. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages
  423. Islet transplantation in IDDM patients
  424. Glucagon improves insulin secretion from pig islets in vitro
  425. Isolation and function of adult pig Islets
  426. Gluten-Free Diet in Subjects at Risk for Type 1 Diabetes: A Tool for Delaying Progression to Clinical Disease?